Your browser doesn't support javascript.
loading
Two-year outcomes in de novo renal transplant recipients receiving everolimus-facilitated calcineurin inhibitor reduction regimen from the TRANSFORM study.
Berger, Stefan P; Sommerer, Claudia; Witzke, Oliver; Tedesco, Helio; Chadban, Steve; Mulgaonkar, Shamkant; Qazi, Yasir; de Fijter, Johan W; Oppenheimer, Federico; Cruzado, Josep M; Watarai, Yoshihiko; Massari, Pablo; Legendre, Christophe; Citterio, Franco; Henry, Mitchell; Srinivas, Titte R; Vincenti, Flavio; Gutierrez, Maria Pilar Hernandez; Marti, Ana Maria; Bernhardt, Peter; Pascual, Julio.
  • Berger SP; Division of Nephrology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Sommerer C; Department of Nephrology, Heidelberg University Hospital, Heidelberg, Germany.
  • Witzke O; Department of Infectious Diseases, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
  • Tedesco H; Department of Nephrology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
  • Chadban S; Nephrology Division, Hospital do Rim, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil.
  • Mulgaonkar S; Department of Renal Medicine and Transplantation, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.
  • Qazi Y; Renal and Pancreas Division, Saint Barnabas Medical Center, Livingston, New Jersey.
  • de Fijter JW; Division of Nephrology, Keck School of Medicine Renal Transplant Program, University of Southern California, Los Angeles, California.
  • Oppenheimer F; LUMC Leids Universitair Medisch Centrum, Leiden, The Netherlands.
  • Cruzado JM; Department of Nephrology and Renal Transplantation, Renal Transplant Unit, Hospital Clinic of Barcelona, Barcelona, Spain.
  • Watarai Y; Hospital Universitari De Bellvitge, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.
  • Massari P; Department of Transplant Surgery, Nagoya Daini Red Cross Hospital, Nagoya-City, Aichi, Japan.
  • Legendre C; Hospital Privado Centro Medico de Cordoba, Cordoba, Argentina.
  • Citterio F; Department of Kidney Transplantation, Adult Transplantation Service, Paris Descartes University and Necker Hospital, Paris, France.
  • Henry M; Agostino Gemelli University Polyclinic Foundation, Catholic University of the Sacred Heart, Rome, Italy.
  • Srinivas TR; Department of Surgery, The Comprehensive Transplant Center, The Ohio State University, Wexner Medical Center, Columbus, Ohio.
  • Vincenti F; Division of Nephrology, Medical University of South Carolina, Mount Pleasant, South Carolina.
  • Gutierrez MPH; Department of Surgery, Kidney Transplant Service, University of California, San Francisco, California.
  • Marti AM; Department of Research and Development, Novartis Pharma AG, Basel, Switzerland.
  • Bernhardt P; Department of Research and Development, Novartis Pharma AG, Basel, Switzerland.
  • Pascual J; Department of Research and Development, Novartis Pharma AG, Basel, Switzerland.
Am J Transplant ; 19(11): 3018-3034, 2019 11.
Article en En | MEDLINE | ID: mdl-31152476

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Complicaciones Posoperatorias / Trasplante de Riñón / Inhibidores de la Calcineurina / Everolimus / Rechazo de Injerto / Supervivencia de Injerto / Fallo Renal Crónico Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Complicaciones Posoperatorias / Trasplante de Riñón / Inhibidores de la Calcineurina / Everolimus / Rechazo de Injerto / Supervivencia de Injerto / Fallo Renal Crónico Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article